Annual Total Long Term Liabilities
$16.88 M
+$3.44 M+25.63%
December 31, 2024
Summary
- As of March 12, 2025, KROS annual total long term liabilities is $16.88 million, with the most recent change of +$3.44 million (+25.63%) on December 31, 2024.
- During the last 3 years, KROS annual total long term liabilities has risen by +$16.65 million (+7208.66%).
- KROS annual total long term liabilities is now at all-time high.
Performance
KROS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$16.88 M
-$546.00 K-3.13%
December 31, 2024
Summary
- As of March 12, 2025, KROS quarterly total long term liabilities is $16.88 million, with the most recent change of -$546.00 thousand (-3.13%) on December 31, 2024.
- Over the past year, KROS quarterly long term liabilities has stayed the same.
- KROS quarterly long term liabilities is now -3.13% below its all-time high of $17.43 million, reached on September 30, 2024.
Performance
KROS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
KROS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.6% | 0.0% |
| 3 y3 years | +7208.7% | +7208.7% |
| 5 y5 years | +182.6% | +182.6% |
KROS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7208.7% | -3.1% | -100.0% |
| 5 y | 5-year | at high | +7208.7% | -3.1% | -100.0% |
| alltime | all time | at high | +7208.7% | -3.1% | -100.0% |
Keros Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $16.88 M(+25.6%) | $16.88 M(-3.1%) |
| Sep 2024 | - | $17.43 M(+35.5%) |
| Jun 2024 | - | $12.86 M(-2.2%) |
| Mar 2024 | - | $13.15 M(-2.1%) |
| Dec 2023 | $13.44 M(+4.9%) | $13.44 M(-1.9%) |
| Sep 2023 | - | $13.70 M(-1.8%) |
| Jun 2023 | - | $13.95 M(-0.3%) |
| Mar 2023 | - | $13.99 M(+9.2%) |
| Dec 2022 | $12.81 M | $12.81 M(>+9900.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $231.00 K(-57.1%) | $231.00 K(-50.7%) |
| Sep 2021 | - | $469.00 K(+71.2%) |
| Jun 2021 | - | $274.00 K(-32.8%) |
| Mar 2021 | - | $408.00 K(-24.2%) |
| Dec 2020 | $538.00 K(-91.0%) | $538.00 K(-18.9%) |
| Sep 2020 | - | $663.00 K(-15.3%) |
| Jun 2020 | - | $783.00 K(-13.1%) |
| Mar 2020 | - | $901.00 K(-84.9%) |
| Dec 2019 | $5.97 M(+87.6%) | $5.97 M |
| Dec 2018 | $3.19 M | - |
FAQ
- What is Keros Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Keros Therapeutics?
- What is Keros Therapeutics annual total long term liabilities year-on-year change?
- What is Keros Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Keros Therapeutics?
- What is Keros Therapeutics quarterly long term liabilities year-on-year change?
What is Keros Therapeutics annual total long term liabilities?
The current annual total long term liabilities of KROS is $16.88 M
What is the all time high annual total long term liabilities for Keros Therapeutics?
Keros Therapeutics all-time high annual total long term liabilities is $16.88 M
What is Keros Therapeutics annual total long term liabilities year-on-year change?
Over the past year, KROS annual total long term liabilities has changed by +$3.44 M (+25.63%)
What is Keros Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of KROS is $16.88 M
What is the all time high quarterly long term liabilities for Keros Therapeutics?
Keros Therapeutics all-time high quarterly total long term liabilities is $17.43 M
What is Keros Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, KROS quarterly total long term liabilities has changed by $0.00 (0.00%)